Tyrosine Kinase Inhibition: A Therapeutic Target for the Management of Chronic-Phase Chronic Myeloid Leukemia
Expert Review of Anticancer Therapy - United Kingdom
doi 10.1586/14737140.2013.859074
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2013
Authors
Publisher
Informa UK Limited